Normalized Absorbed Doses for Organs at Risk (Gy/GBq) and Normalized Effective Dose (mSv/MBq)
Organ | Patient no. | Median | Mean | SD | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 6 | 7 | 8 | 9 | ||||
Red marrow | 0.326 | 0.346 | 0.564 | 0.499 | 0.301 | 0.206 | 0.226 | 0.375 | 0.336 | 0.355 | 0.116 |
Kidneys | 0.063 | 0.097 | 0.054 | 0.053 | 0.078 | 0.094 | 0.250 | 0.691 | 0.086 | 0.172 | 0.205 |
Bone surfaces | 1.080 | 1.180 | 1.980 | 1.780 | 1.040 | 0.635 | 0.641 | 1.220 | 1.130 | 1.195 | 0.450 |
Effective dose | 0.143 | 0.130 | 0.216 | 0.177 | 0.109 | 0.095 | 0.106 | 0.158 | 0.137 | 0.142 | 0.038 |
Maximum tolerated injected activity (GBq) | 6.1 | 5.8 | 3.5 | 4.0 | 6.6 | 9.7 | 8.8 | 5.3 | 6.0 | 6.3 | 2.0 |
Dose-limiting organ is red marrow.